Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Gross Margin (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Gross Margin data on record, last reported at 71.46% in Q4 2025.

  • For Q4 2025, Gross Margin fell 403.0% year-over-year to 71.46%; the TTM value through Dec 2025 reached 61.97%, down 1402.0%, while the annual FY2025 figure was 61.97%, 1402.0% down from the prior year.
  • Gross Margin reached 71.46% in Q4 2025 per ORGO's latest filing, up from 64.73% in the prior quarter.
  • Across five years, Gross Margin topped out at 78.05% in Q2 2022 and bottomed at 27.48% in Q2 2025.
  • Average Gross Margin over 5 years is 72.5%, with a median of 75.38% recorded in 2024.
  • Peak YoY movement for Gross Margin: soared 558bps in 2021, then crashed -5010bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 74.51% in 2021, then grew by 3bps to 76.53% in 2022, then decreased by -6bps to 72.13% in 2023, then rose by 5bps to 75.48% in 2024, then dropped by -5bps to 71.46% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 71.46% in Q4 2025, 64.73% in Q3 2025, and 27.48% in Q2 2025.